[#2005-01] Erinacine A increases catecholamine and nerve growth factor content in the central nervous system of rats, Mari Shimbo et al.

Erinacine A increases catecholamine and nerve growth factor content in the central nervous system of rats

Mari Shimbo, Hirokazu Kawagishi, Hidehiko Yokogoshi

Abstract

Nerve growth factor (NGF) is an essential protein for supporting growth and maintenance of peripheral sympathetic neurons. A novel diterpenoid erinacine, isolated from the cultured mycelia of Hericium erinacium ( lion’s mane ), is known to have a potent stimulating effect on NGF synthesis. The effects of erinacine and related compounds in the brain in vivo are not known. In this study, we examined the effects of erinacine A on the production of NGF and catecholamines which stimulate NGF synthesis in the brain of rats. Rats were treated with erinacine A by incubation for the first, 3 weeks from birth to weaning and intragastrically from weeks 4 to 5. Rats treated with this compound had increased levels of both noradrenaline and homovanillic acid in the locus coeruleus (LC) at 4 weeks of age and increased levels of NGF in both LC and hippocampus at 5 weeks of age. The effects of erinacine A were confirmed in the central nervous system in rats.